In contrast, SDC1 mediates EMT in prostate cancer [171] and the expression of SDC1 (and also SDC2) is correlated with EMT markers (E-cadherin, β-catenin) in prostate cancer [172]. Here, SDC2 is linked to prostate carcinoma.